Wednesday, August 26, 2026 The Canadian Cancer Society recently announced a $525,000 Challenge Grant award for a CO.21 implementation study. The Challenge Grants program supports cancer research projects that are focused on solving a cancer related problem.The landmark CCTG CO.21clinical trial demonstrated that a lifestyle intervention reduced the risk of disease recurrence by 28% and improved survival by 37%. This groundbreaking trial revolutionized how exercise interventions are viewed as a necessary treatment option. The next step is to ensure that this important intervention is made available through sustainable delivery that is embedded within the Canadian healthcare system. CO-PIs Dr Kristin Campbell and Dr Lauren Capozzi are creating a practical plan to bring structured exercise programs into cancer treatment clinics worldwide. They will test the plan at BC Cancer Kelowna, then develop a national policy and advocacy strategy to support the adoption across Canada.Objectives for CO.21 IMPACT Grant include: Collaborate with diverse knowledge users to co-design an adaptable implementation blueprint to support the adoption of CO.21 into clinical careEvaluate the reach and implementation of CO.21 IMPACT as part of a clinic-embedded direct referral pathway for people diagnosed with stage II-III colon cancer treated at BC Cancer Kelowna Centre using the RE-AIM FrameworkDevelop a policy case to support advocacy for adoption of CO.21 IMPACT by health systems, insurance providers, and community organizations. Grant ApplicantsKirsten Campbell (Co-PI)Lauren Capozzi (Co-PI)Chris BoothKerry Courneya Chris O’Callaghan Terry Swain-CollinsNunez JJ Lim HMcNeely MNeil-Sztramko STrinh LBland K Liu YA Cameron B
